Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 271 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA184379
National Institutes of Health
Grant: CA242188
National Institutes of Health
Grant: CA237149
National Institutes of Health
Grant: AG067441
National Institutes of Health
Grant: S10OD025246
NCI NIH HHS
Grant: R01 CA184379
NCI NIH HHS
Grant: R01 CA242188
NIA NIH HHS
Grant: R21 AG067441
NCI NIH HHS
Grant: R01 CA237149
Melanoma Research Alliance
MeSH Terms
Additional file 1 of A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer
Additional file 1 of A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer
Additional file 1 of CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis
Additional file 1 of CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis
Additional file 2 of A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer
Additional file 2 of A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer